Factory Supply API Grade Pharmaceutical Intermediate Enrofloxacin HCl Raw Powder CAS 112732-17-9 Bulk Enrofloxacin Hydrochloride with Best Price

• Powder: Yes
• Customized: Customized
• Certification: ISO 9001
• Suitable for: Adult
• State: Solid
• Purity: >99%
• Mf: C19h22fn3o3
• Appearance: White Powder
• MOQ: 1kg
• Grade: Pharmaceutical Grade
• Test Method: HPLC
• Mesh: 100% Pass 80 Mesh
• OEM Service: Accept
• MSDS: Available
• Shelf Life: 2 Years
• CAS Number: 112732-17-9
• Einecs: 688-293-7
• Molecular Weight: 395.86
• Transport Package: Paper Bag or Drum
• Specification: 1kg/bag; 25kg/drum
• Trademark: Greenway Biotech
• Origin: China
• HS Code: 2942000000
• Production Capacity: 1000kg/Year

Product Description

Factory Supply API Grade Pharmaceutical Intermediate Enrofloxacin Hcl Raw Powder
CAS 112732-17-9 Bulk Enrofloxacin Hydrochloride with Best Price

Product Name	Enrofloxacin Hydrochloride
Brand Name	Greenway Biotech
Purity	99%
MF	C19H22FN3O3
Appearance	White Powder
Test Method	HPLC

Enrofloxacin HCL is a broad spectrum bactericidal drugs,have special effects on mycoplasma.
White on escherichia coli, klebsiella bacillus coli,pseudomonas aeruginosa,salmonella,deformation,
haemophilus, kill,pasteurella,streptococcus hemolytic pap coli,s.aureus bacteria, such as have
antiseptic effect.







Application:

1. Dogs and Cats

The product is indicated in the treatment of bacterial infections of the alimentary, respiratory
and urogenital tracts, skin, secondary wound infections and otitis externa where clinical
experience, supported where possible by sensitivity testing of the causal organism, indicates
enrofloxacin as the drug of choice.

2. Cattle

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g.
pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and
secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where
clinical experience, supported where possible by sensitivity testing of the causal organism,
indicates enrofloxacin as the drug of choice.

3. Pigs

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g.
pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis)
and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical
experience, supported where possible by sensitivity testing of the causal organism, indicates
enrofloxacin as the drug of choice